Skip to main content
letter
. 2020 Sep 28;49(1):e105–e107. doi: 10.1097/CCM.0000000000004674

TABLE 1.

Demographic and Clinical Characteristics for Study Cohort, Survivors, and Nonsurvivors

Variables All Patients Survivors Nonsurvivors
Number of patients (%) 242 151 (62.4) 91 (37.6)
Age, yr, median (IQR) 59 (51–65) 56 (47–63) 61 (57–67)
Males, n (% total patients) 174 (71.9) 105 (60.3) 69 (39.7)
Females, n (% total patients) 68 (28.1) 46 (67.6) 22 (32.4)
Body mass index, kg/m2, median (IQR) 27.6 (24.45–55.5) 27.6 (24.7–32.7) 27.34 (23.9–30.2)
ICU length of stay, d, median (IQR) 14.0 (5.1–30.0) 15.1 (4.9–34.7) 12.0 (5.8–20.0)
Advanced respiratory support daysa, d, median (IQR) 12.5 (4.0–25.0) 12.0 (3.0–29.0) 13.0 (6.0–19.0)
Advanced renal support daysb, d, median (IQR) 0 (0.0–4.0) 0 (0.0–6.0) 0 (0.0–2.0)
APACHE II, median (IQR) 16.0 (11.0–20.0) 14.0 (10.0–19.0) 17.5 (13.0–21.8)
Predicted mortality calculated from median APACHE II score, % 23.5 18.6 29.1
SAPS II, median (IQR) 29 (21–38) 27 (20–34) 33 (25–41)
Predicted mortality calculated from median SAPS II score, % 9.7 7.9 14.0
Intensive Care National Audit and Research Centre, median (IQR) 22.5 (17.0–28.7) 20.9 (17.0–27.0) 26.0 (18.5–65.6)

APACHE = Acute Physiology and Chronic Health Evaluation, IQR = interquartile range, SAPS = Simplified Acute Physiology Score.

aAdvanced respiratory support: mechanical ventilatory support via endotracheal tube or extracorporeal respiratory support.

bAdvanced renal support: acute renal replacement therapy or provision of renal replacement therapy to a chronic renal failure patient who is requiring other acute organ support.